Fentanyl: Are we paying too high a price?

Authors

  • Vincenzo Fodale, MD
  • Manuela Romeo, MD
  • Federica Mafrica, MD

DOI:

https://doi.org/10.5055/jom.2007.0049

Keywords:

-

Abstract

-

Author Biographies

Vincenzo Fodale, MD

Aggregate Professor of Anesthesiology and Intensive Care, Department of Neuroscience, Psychiatric and Anesthesiological Sciences, University of Messina School of Medicine, Messina, Italy.

Manuela Romeo, MD

School of Medicine and Surgery, University of Messina, Messina, Italy.

Federica Mafrica, MD

Research Residents Program, Anesthesia Intensive Care, Department of Neuroscience, Psychiatric and Anesthesiological Sciences, University of Messina School of Medicine, Messina, Italy.

References

Boddiger D: Fentanyl-laced street drugs “kill hundreds.” Lancet. 2006; 368(9535): 569-570.

Fodale V, Mafrica F, Santamaria LB: Killer fentanyl: A lesson from anaesthesiology. Lancet. 2006; 368(9543): 1237-1238.

Drummer OH: Recent trends in narcotic deaths. Ther Drug Monit. 2005; 27(6): 738-740.

Henderson GL: Designer drugs: Past history and future prospects. JForensic Sci. 1988; 33(2): 569-575.

Henderson GL: Fentanyl-related deaths: Demographics, circumstances, and toxicology of 112 cases. J Forensic Sci. 1991; 36(2): 422-433.

Siegel RK: New trends in drug use among youth in California. Bull Narc. 1985; 37(2-3): 7-17.

Smialek JE, Levine B, Chin L, et al.: A fentanyl epidemic in Maryland 1992. J Forensic Sci. 1994; 39(1): 159-164.

Bicudo JN, de Souza N, Mangia CM, et al.: Withdrawal syn-drome associated with cessation of fentanyl and midazolam in pediatrics. Rev Assoc Med Bras. 1999; 45(1): 15-18.

Takara I, Tomiyama H, Tokumine J, et al.: [Withdrawal syn-drome in a critically ill child after sedation with midazolam and fentanyl]. Masui. 20o4; 53(7): 791-794.

Cammarano WB, Pittet JF, Weitz S, et al.: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998; 26(4): 676-684.

Anderson DT, Muto JJ: Duragesic transdermal patch: Postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000; 24(7): 627-634.

Kuhlman JJ Jr, McCaulley R, Valouch TJ, et al.: Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases. J Anal Toxicol. 2003; 27(7): 499-504.

Jin M, Gock SB, Jannetto PJ, et al.: Pharmacogenomics as molecular autopsy for forensic toxicology: Genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol. 2005; 29(7): 590-598.

Shavit Y, Ben-Eliyahu S, Zeidel A, et al.: Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004; 11(4): 255-260.

Franck LS, Naughton I, Winter I: Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004; 20(6): 344-351.

Taha J, Favre J, Janszen M, et al.: Correlation between with-drawal symptoms and medication pump residual volume in patients with implantable Synchro Med pumps. Neurosurgery. 2004; 55: 390-393.

Jackson FW: Fentanyl and the wooden chest. Gastroenterology. 1994; 106(3): 820-821.

Viscomi CM, Bailey PL: Opioid-induced rigidity after intra-venous fentanyl. Obstet Gynecol. 1997; 89(5 Pt 2): 822-824.

Bouillon T, Bruhn J, Roepcke H, et al.: Opioid-induced res-piratory depression is associated with increased tidal volume variability. Eur J Anaesthesiol. 2003; 20(2): 127-133.

Clark JD, Edwards T: Severe respiratory depression in a patient with gastroparesis while receiving opioids for pain. Clin J Pain. 1999; 15(4): 321-323.

McLoughlin R, McQuillan R: Transdermal fentanyl and respi-ratory depression. Palliat Med. 1997; 11(5): 419.

Tsou CH, Luk HN: Fentanyl-induced coughing and airway hyperresponsiveness. Acta Anaesthesiol Sin. 2002; 40(4): 165172.

Ananthanarayan C: Tussive effect of fentanyl. Anaesthesia. 1990; 45(7): 595.

Arandia HY, Patil VU: Glottic closure following large doses of fentanyl. Anaesthesiology. 1987; 66(4): 574-575.

Gin T, Chui PT: Coughing after fentanyl. Can J Anaesth. 1992; 39(4): 406.

Yu SY, Sun Y, Wu YL, et al.: [Transdermal fentanyl for the management of cancer pain: A survey of 4492 patients]. ZhonghuaZhongLiu Za Zhi. 2005; 27(6): 369-372.

Okamura K, Sanuki M, Kinoshita H, et al.: [Study of nausea and vomiting accompanying intravenous patient-controlled analgesia with fentanyl after cervical spine surgery]. Masui. 2003; 52(11): 1181-1185.

Hansen-Flaschen J, Adler BS: Allegations of sexual abuse in an intensive care unit. Crit Care Med. 1999; 27(2): 437-440.

Nevin J: Drug update: Fentanyl patch abuse. Emerg Med Serv. 2004; 33(7): 24-25.

Compton WM, Volkow ND: Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83 Suppl 1: S4-S7.

Lilleng PK, Mehlum LI, Bachs L, et al.: Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci. 2004; 49(6): 1364-1366.

Jost U, Wolter E, Bohrer H: [Repeated improper intravenous injection of fentanyl from a transdermal system]. Dtsch Med Wochenschr. 2004; 129(7): 313-314.

Holth LS, Friesen R, Green C, et al.: A simple method for quantifying fentanyl, sufentanil, or morphine in discard syringes from anesthesia procedures. TherDrugMonit. 2002; 24(5): 665669.

Moore NN, Bostwick JM: Ketamine dependence in anaesthesia providers. Psychosomatics. 1999; 40(4): 356-359.

Kintz P, Villain M, Dumestre V, et al.: Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic SciInt. 2005; 153(1): 81-84.

Schwartz JG, Garriott JC, Somerset JS, et al.: Measurements of fentanyl and sufentanil in blood and urine after surgical application. Implication in detection of abuse. Am J Forensic Med Pathol. 1994; 15(3): 236-241.

Gold MS, Byars JA, Frost-Pineda K: Occupational exposure and addictions for physicians: Case studies and theoretical implications. Psychiatr Clin North Am. 2004; 27(4): 745-753.

McAuliffe PF, Gold MS, Bajpai L, et al.: Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses. 2006; 66(5): 874-882.

Gold MS, Melker RJ, Dennis DM, et al.: Fentanyl abuse and dependence: Further evidence for second hand exposure hypothesis. J Addict Dis. 2006; 25(1): 15-21.

Domino KB, Hornbein TF, Polissar NL, et al.: Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005; 293(12): 1513-1515.

Ward CF, Ward GC, Saidman LJ: Drug abuse in anesthesia training programs. A survey: 1970 through 1980. JAMA. 1983; 250(7): 922-925.

Thompson ES: Where is the fentanyl? Anesthesiology. 2004; 101(1): 265.

Skulska A, Kala M, Parczewski A: Fentanyl and its analogues in clinical and forensic toxicology. PrzLek. 2005; 62(6): 581-584.

Downloads

Published

05/01/2007

How to Cite

Fodale, MD, V., M. Romeo, MD, and F. Mafrica, MD. “Fentanyl: Are We Paying Too High a Price?”. Journal of Opioid Management, vol. 3, no. 3, May 2007, pp. 123-6, doi:10.5055/jom.2007.0049.

Issue

Section

Editorial